Literature DB >> 19508900

Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers.

Steve H Kye1, Donald P Tashkin, Michael D Roth, Bradley Adams, Wen-Xian Nie, Jenny T Mao.   

Abstract

The ability to recruit qualified subjects who are willing to adhere to the study protocol in clinical trials is an essential component of translational research. Such tasks can be particularly challenging for chemoprevention studies when the targeted study population is healthy, at risk individuals who do not have signs or symptoms of the disease, and the study participation involves complex scheduling and invasive procedures such as bronchoscopy. In this report, we describe the recruitment process and evaluated the effectiveness of various recruitment strategies utilized in our National Cancer Institute sponsored lung cancer chemoprevention study with celecoxib. Heavy ex-smokers were recruited into the study through various methods such as radio advertisements, print media, mass mailings, flyers, internet postings and others. The number of inquiries, on-site screenees and randomization generated by each method determined the efficacy of that recruitment strategy. We prescreened 4470 individuals, invited 323 people for on-site screening and randomized 137 subjects. Radio advertisements (ads) generated the most inquiries (71.1%), followed by internet posting (11.8%), print media (6.0%), posted and racked flyers (4.4%), mass mailings (2.7%) and other strategies such as referrals from friends or family members or health care providers (2.3%). Radio ads, although costly, yielded the most subjects for on-site screening and randomization. Moreover, among the various types of radio stations, news radio stations were by far the most successful. Our results suggest that advertising on news radio is a highly effective recruitment method for successful accrual of ex-smokers into lung cancer chemoprevention trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508900     DOI: 10.1016/j.cct.2009.05.004

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  11 in total

1.  A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers.

Authors:  Arash Mohebati; Allison Knutson; Xi Kathy Zhou; Judith J Smith; Powel H Brown; Andrew J Dannenberg; Eva Szabo
Journal:  Contemp Clin Trials       Date:  2012-07-05       Impact factor: 2.226

2.  Lung cancer chemoprevention with celecoxib in former smokers.

Authors:  Jenny T Mao; Michael D Roth; Michael C Fishbein; Denise R Aberle; Zuo-Feng Zhang; Jian Yu Rao; Donald P Tashkin; Lee Goodglick; E Carmack Holmes; Robert B Cameron; Steven M Dubinett; Robert Elashoff; Eva Szabo; David Elashoff
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

3.  Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer.

Authors:  Nagi Kumar; Theresa Crocker; Tiffany Smith; Julio Pow-Sang; Philippe E Spiess; Kathleen Egan; Gwen Quinn; Michael Schell; Said Sebti; Aslam Kazi; Tian Chuang; Raoul Salup; Mohamed Helal; Gregory Zagaja; Edouard Trabulsi; Jerry McLarty; Tajammul Fazili; Christopher R Williams; Fred Schreiber; Joel Slaton; J Kyle Anderson
Journal:  Contemp Clin Trials       Date:  2011-11-11       Impact factor: 2.226

4.  Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer.

Authors:  Nagi B Kumar; Gwendolyn P Quinn; Mark G Alexandrow; Jhanelle Gray; Michael Schell; Steve Sutton; Eric B Haura
Journal:  J Clin Trials       Date:  2014-09

Review 5.  Interventions for recruiting smokers into cessation programmes.

Authors:  José S Marcano Belisario; Michelle N Bruggeling; Laura H Gunn; Serena Brusamento; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

6.  Recruitment strategies for caregivers of children with mental health problems.

Authors:  Ukamaka M Oruche; Janis E Gerkensmeyer; Joan K Austin; Susan M Perkins; Eric Scott; Laura M Lindsey; Kristen Mullins
Journal:  Clin Nurse Spec       Date:  2012 Jul-Aug       Impact factor: 1.067

7.  Randomized phase II trial of sulindac for lung cancer chemoprevention.

Authors:  Paul J Limburg; Sumithra J Mandrekar; Marie Christine Aubry; Katie L Allen Ziegler; Jun Zhang; Joanne E Yi; Michael Henry; Henry D Tazelaar; Stephen Lam; Annette McWilliams; David E Midthun; Eric S Edell; Otis B Rickman; Peter Mazzone; Melvyn Tockman; John F Beamis; Carla Lamb; Michael Simoff; Charles Loprinzi; Eva Szabo; James Jett
Journal:  Lung Cancer       Date:  2012-12-20       Impact factor: 5.705

8.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

9.  'I heard about this study on the radio': using community radio to strengthen Good Participatory Practice in HIV prevention trials.

Authors:  Bonnie-Jeanne Medeossi; Jonathan Stadler; Sinead Delany-Moretlwe
Journal:  BMC Public Health       Date:  2014-08-26       Impact factor: 3.295

Review 10.  Participation in research bronchoscopy: a literature review.

Authors:  Einar Marius Hjellestad Martinsen; Elise Orvedal Leiten; Per Sigvald Bakke; Tomas Mikal Lind Eagan; Rune Grønseth
Journal:  Eur Clin Respir J       Date:  2016-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.